Selected Image

What is it?

Bovilis Nasalgen®-C is an intranasal, live vaccine which can be used for active immunisation of calves from the day of birth onward to reduce clinical signs of upper respiratory disease and nasal viral shedding from infection with Bovine Coronavirus (BCoV).

Bovilis Nasalgen®-C allows farmers and veterinarians to safely and effectively administer protection against BCoV in a single intranasal vaccination that can quickly reach the site of action. The onset of immunity starts five days after administration, with a 12-week duration. Bovilis Nasalgen®-C can be used concurrently with Bovilis INtranasal RSP® Live. 

Why use it:

BCoV is quite prevalent in Irish herds, featuring strongly in calves and is much less prominent in older animals. It likes having a partner in that it is frequently co-detected with other BRD viruses such as Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (PI3).

In terms of bacterial causes of Bovine Respiratory Disease (BRD), it is most commonly detected with Mycoplasma Bovis and Mannheimia Haelmolytica, which can have a long-term impact on the health and productivity of the herd.BRD is the most significant cause of deaths among calves greater than one month of age. BRD has a huge negative impact on growth and performance of both beef and dairy animals. Therefore, Consequences of the disease can manifest later in life with decreased milk production in the first lactation and decreased daily weight gain. For example, a dairy heifer calf can produce up to 120 kg less in her first lactation while beef animals can take up to 2 months longer to finish.

How to use:

Route of Administration:  Intranasally

Dose: 2 ml

Calves can be vaccinated with Bovilis Nasalgen-C from the Day of Birth. Vaccinated calves will have protection against respiratory BCoV within 5 days of vaccination. The duration of protection against this virus is 12 weeks.

Bovilis Nasalgen®-C can be used concurrently with Bovilis INtranasal RSP® Live, which offers protection against both BRSV and PI3. Both can be administered from the day of birth, 2 ml into either nostril.

dairy calf beef calf

Related Video

To activate the video player please allow cookies in category ‘Performance and Operation’ and refresh this page.

  • Reducing Abortion Rates in Your Flock: Enzootic Abortion of Ewes and Toxoplasmosis
    Eleanor Brady, MVB MRCVS, Ruminant Veterinary Manager, MSD Animal Health Many Irish flocks will experience a few abortions each year, but how many abortions is too many? Targets for abortion and overall empty rate are set at <2% and <5% respectively, although many flock owners accept rates higher than this. Approximately one third of lamb … Read more
  • IBR Vaccination of Youngstock
    Helena Madden MVB MRCVS Cert DHH Ruminant veterinary manager MSD Animal Health IBR – Infectious bovine rhinotracheitis Infection with IBR virus is widespread in the cattle population in Ireland, with evidence of exposure in over 70% of herds (both beef and dairy).  It is capable of causing disease (both clinical and subclinical) resulting in significant … Read more
  • Reducing the risk of pneumonia in calves at turnout
    Sarah Higgins MVB MRCVS CertAVP, Ruminant & Equine Veterinary Manager, MSD Animal Health Respiratory disease is commonly seen in both dairy and suckler calves. Pneumonia is the most significant cause of death in cattle greater than one month of age in Ireland. There are substantial long term implications of respiratory disease on productivity for both … Read more

“Animal Health Ireland estimate the annual cost of BVD to Irish herds totals €102 million.”

Sign up to Bovilis® product and event information